Adicet Bio Inc (ACET)
1.31
+0.05
(+3.97%)
USD |
NASDAQ |
Nov 05, 16:00
1.31
0.00 (0.00%)
After-Hours: 20:00
Adicet Bio Total Liabilities (Quarterly): 33.73M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 33.73M |
| March 31, 2024 | 34.29M |
| December 31, 2023 | 37.12M |
| September 30, 2023 | 38.58M |
| June 30, 2023 | 38.57M |
| March 31, 2023 | 38.76M |
| December 31, 2022 | 38.35M |
| September 30, 2022 | 36.64M |
| June 30, 2022 | 36.64M |
| Date | Value |
|---|---|
| March 31, 2022 | 29.37M |
| December 31, 2021 | 35.81M |
| September 30, 2021 | 39.97M |
| June 30, 2021 | 40.44M |
| March 31, 2021 | 45.81M |
| December 31, 2020 | 44.01M |
| September 30, 2020 | 33.47M |
| December 31, 2019 | 141.95M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
29.37M
Minimum
Mar 2022
141.95M
Maximum
Dec 2019
43.74M
Average
38.35M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 9.613M |
| IGC Pharma Inc | 2.714M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Protalix BioTherapeutics Inc | 62.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 268.84M |
| Shareholders Equity (Quarterly) | 235.11M |